Abbott (ABT) Stock Sinks Despite EPS Match as Revenue Miss Sparks Selloff
Abbott stock fell more than 7% in premarket trading after the company missed on Q4 revenue and gave a weaker Q1 2026 outlook, even with earnings…
BTC$63,123.00+0.60%
ETH$1,772.86+0.35%
USDT$0.9991+0.01%
USDC$0.9999+0.01%
XRP$1.12-1.81%
SOL$80.87+0.28%
TRX$0.3301+1.13%
FIGR_HELOC$1.04-0.52%
HYPE$71.30+1.03%
DOGE$0.0744-3.51%
USDS$0.9997-0.01%
RAIN$0.015-0.44%
LEO$9.40+0.45%
ZEC$452.28+1.55%
WBT$56.14-1.01%
BTC$63,123.00+0.60%
ETH$1,772.86+0.35%
USDT$0.9991+0.01%
USDC$0.9999+0.01%
XRP$1.12-1.81%
SOL$80.87+0.28%
TRX$0.3301+1.13%
FIGR_HELOC$1.04-0.52%
HYPE$71.30+1.03%
DOGE$0.0744-3.51%
USDS$0.9997-0.01%
RAIN$0.015-0.44%
LEO$9.40+0.45%
ZEC$452.28+1.55%
WBT$56.14-1.01%
Rocket Lab shares dropped more than 5% after a Stage 1 tank rupture during Neutron rocket testing raised timeline concerns.
Abbott stock fell more than 7% in premarket trading after the company missed on Q4 revenue and gave a weaker Q1 2026 outlook, even with earnings…
GameStop stock climbed in premarket trading after Ryan Cohen bought another 500,000 shares and increased his ownership in the company.
Moderna stock rose over 7% after the company and Merck said their personalized melanoma vaccine kept working at five years, cutting recurrence or death risk by…
Intel stock rose in premarket trading as investors looked ahead to Q4 earnings, betting CEO Lip-Bu Tan’s turnaround plan is gaining traction and data center demand…
Netflix fell in premarket despite beating Q4 estimates, as weaker growth trends and the Warner Bros. Discovery deal overhang pressured sentiment.
Despite surpassing its average analyst price target, Micron’s forward valuation and memory bottleneck economics point toward a credible path to $500 by 2026.
RAPT Therapeutics stock surged over 63% after GSK agreed to buy the company for $58 per share in a $2.2 billion deal.
With risk assets retreating and commodities exploding higher, investors are hunting for durable growth stories trading below consensus value.
ImmunityBio shares jumped in premarket trading after the FDA outlined next steps for expanding ANKTIVA’s bladder cancer label.
Critical Metals stock jumped in premarket trading as fresh headlines around Greenland reignited investor interest in the company’s Tanbreez rare earths project.
State Street shares slipped after the bank posted a Q4 earnings and revenue beat, but investors focused on restructuring costs and a higher-than-expected expense outlook for…
QXO stock declined over 6% in premarket trading after announcing a 31.6 million share offering priced at $23.80, below its previous close.